AstraZeneca PLC
AZN.LFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
66,180
Cost of Revenue
16,557
Gross Profit
49,623
Gross Margin
75.0%
Operating Income
15,652
Operating Margin
23.7%
Net Income
8,610
Net Margin
13.0%
EPS (Basic)
$6.00
EPS (Diluted)
$6.00
EBITDA
18,573
EBITDA Margin
28.1%
2023
12/31/2023
Revenue
58,229
Cost of Revenue
15,169
Gross Profit
43,060
Gross Margin
73.9%
Operating Income
11,962
Operating Margin
20.5%
Net Income
7,569
Net Margin
13.0%
EPS (Basic)
$5.00
EPS (Diluted)
$5.00
EBITDA
16,495
EBITDA Margin
28.3%
2022
12/31/2022
Revenue
55,317
Cost of Revenue
20,267
Gross Profit
35,050
Gross Margin
63.4%
Operating Income
6,311
Operating Margin
11.4%
Net Income
4,101
Net Margin
7.4%
EPS (Basic)
$3.00
EPS (Diluted)
$3.00
EBITDA
10,787
EBITDA Margin
19.5%
2021
12/31/2021
Revenue
46,384
Cost of Revenue
18,135
Gross Profit
28,249
Gross Margin
60.9%
Operating Income
3,511
Operating Margin
7.6%
Net Income
137
Net Margin
0.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
5,732
EBITDA Margin
12.4%
2020
12/31/2020
Revenue
36,588
Cost of Revenue
9,510
Gross Profit
27,078
Gross Margin
74.0%
Operating Income
6,212
Operating Margin
17.0%
Net Income
4,238
Net Margin
11.6%
EPS (Basic)
$3.00
EPS (Diluted)
$3.00
EBITDA
10,044
EBITDA Margin
27.5%